Claritin and Aura - a phase IV clinical study of FDA data

Summary:

Aura is reported as a side effect among people who take Claritin (loratadine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Cymbalta, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Aura when taking Claritin. It is created by eHealthMe based on reports of 74,516 people who have side effects when taking Claritin from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

What is Aura?

Aura is found to be associated with 179 drugs and 399 conditions by eHealthMe. Check the latest studies of Aura.

On Jul, 12, 2026

74,516 people reported to have side effects when taking Claritin.
Among them, 11 people (0.01%) have Aura.

Among these 11 people:

How long have people been on Claritin when they have Aura? *

What is the gender of people who have Aura when taking Claritin? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Aura when taking Claritin? *

What are other drugs people take besides Claritin? *

What are other side effects people have besides Aura? *

Dizziness: 5 people, 45.45%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Chest Pain: 3 people, 27.27%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 27.27%
Diarrhea: 3 people, 27.27%
Fatigue (feeling of tiredness): 3 people, 27.27%
Weight Increased: 2 people, 18.18%
Feeling Abnormal: 2 people, 18.18%
Flatulence (flatus expelled through the anus): 2 people, 18.18%
Hypometabolism (abnormal decrease in metabolic rate): 2 people, 18.18%

What are the existing conditions these people have? *

Hypersensitivity: 3 people, 27.27%
Multiple Allergies (allergy to multiple agents): 2 people, 18.18%
Brain Neoplasm Malignant (brain cancer tumour): 2 people, 18.18%
Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 9.09%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 9.09%
Lyme Disease (a bacterial infection that is spread to humans by infected ticks): 1 person, 9.09%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and have Aura?

- Check whether Aura is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Claritin:

Claritin (77,315 reports)

Aura treatments and more:

Aura (2,124 reports)

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aura:

Aura (179 drugs)

Browse all the conditions that are associated with Aura:

Aura (399 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loratadine (the active ingredients of Claritin) and Claritin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.